ABL Diagnostics and VELA Dx Expand Strategic Partnership with Key Commercial and Technical Milestones in EMEA
WOIPPY, FRANCE, November 4, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, today announced several major developments in its partnership with VELA Diagnostics ( …